Article Text
PDFEditorial
Don’t do the blood* test!!
Statistics from Altmetric.com
Footnotes
Contributors Based on a discussion-shared idea: JP wrote the first draft and both authors were involved in subsequent revisions.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests GF is co-editor of Practical Neurology.
Patient consent for publication Not required.
Provenance and peer review Commissioned. Externally peer reviewed by Tony Marson, Liverpool, UK.
Read the full text or download the PDF:
Other content recommended for you
- Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis
- Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease
- Autocrine MMP-2/9 secretion increases the BBB permeability in neuromyelitis optica
- Ring-enhancing spinal cord lesions in neuromyelitis optica spectrum disorders
- Current concept of neuromyelitis optica (NMO) and NMO spectrum disorders
- A practical approach to the diagnosis of spinal cord lesions
- Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination
- Silent progression of brain atrophy in aquaporin-4 antibody-positive neuromyelitis optica spectrum disorder
- No evidence of misdiagnosis in patients with multiple sclerosis and repeated positive anticardiolipin antibody testing based on magnetic resonance imaging and long term follow-up
- Neurodegeneration in multiple sclerosis and neuromyelitis optica